Viracta Therapeutics Q2 EPS $(0.25) Up From $(15.52) YoY

Viracta Therapeutics (NASDAQ:VIRX) reported quarterly losses of $(0.25) per share. This is a 98.39 percent increase over losses of $(15.52) per share from the same period last year.